U.S. market Closed. Opens in 17 hours 10 minutes

CRNX | Crinetics Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue4.01M4.74M1.08M71.00K1.19M2.43M2.04M589.00K
Cost of Revenue1.10M1.39M1.26M57.00M1.11MN/AN/AN/A
Gross Profit2.92M3.35M-184.00K-56.93M80.00K2.43MN/AN/A
Operating Expenses225.52M172.62M108.78M74.95M53.83M28.71M11.17M6.63M
Selling, General & Admin58.09M42.39M24.52M18.03M13.52M6.66M1.94M1.53M
Research & Development167.43M130.22M84.25M57.00M41.51M24.48M9.23M5.10M
Other Operating Expenses-159.00K4.97M61.00K-71.00K-1.19M1.59MN/AN/A
Operating Income-222.61M-167.88M-107.70M-74.95M-53.83M-28.71M-9.13M-6.04M
Other Expenses / Income8.08M3.96M61.00K1.14M3.41M1.59M-30.00K25.00K
Before Tax Income-214.53M-163.92M-107.64M-73.81M-50.42M-27.11M-9.16M-6.02M
Income Tax Expenses930.11K-3.96M-922.00K-948.00K-887.00K1.59MN/AN/A
Net Income-214.53M-159.95M-106.72M-72.86M-49.53M-27.11M-9.16M-6.02M
Interest ExpensesN/A4.32MN/AN/AN/AN/A8.00K11.00K
Basic Shares Outstanding58.07M51.98M38.44M30.45M24.18M12.14M7.75M13.88M
Diluted Shares Outstanding58.07M51.98M38.44M30.45M24.18M12.14M7.75M13.88M
EBITDA-221.51M-167.88M-107.70M-74.95M-53.83M-28.71M-9.02M-5.92M
EBITDA Margin-5,519.81%-3,544.06%-9,990.91%-105,567.61%-4,512.32%-1,182.45%-441.12%-1,004.41%
EBIT-213.60M-159.60M-107.64M-73.81M-50.42M-25.52M-9.15M-6.01M
EBIT Margin-5,322.67%-3,369.24%-9,985.25%-103,960.56%-4,226.49%-1,051.07%-447.38%-1,020.03%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙